Keeping Track Of New Drugs: US FDA Review Queue Adds Spark Gene Therapy, Amgen Migraine Antibody, Bayer Oncologic

 
• By Bridget Silverman

The latest news about novel agent applications from our FDA Performance Tracker.

Keeping Track Feature image

More from Approvals

More from Product Reviews